Chris Bulman’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Buy
1,353
+115
+9% +$26.8K 0.13% 110
2026
Q1
$303K Sell
1,238
-95
-7% -$22.1K 0.13% 102
2025
Q4
$276K Buy
+1,333
New +$264K 0.12% 107
2025
Q2
Sell
-2,348
Closed -$389K 130
2025
Q1
$389K Buy
2,348
+124
+6% +$19.4K 0.25% 74
2024
Q4
$322K Buy
2,224
+92
+4% +$14.3K 0.21% 78
2024
Q3
$345K Buy
2,132
+26
+1% +$4.14K 0.24% 72
2024
Q2
$308K Buy
+2,106
New +$313K 0.21% 72

Other funds holding JNJ

Chris Bulman's JNJ Position: Q2 2026 in Review

Chris Bulman increased its Johnson & Johnson (JNJ) stake by 9.3% in Q2 2026, buying an estimated $26.8K and bringing the position to 1,353 shares worth $344K. The position accounts for 0.13% of the portfolio, ranked #110.

Chris Bulman first reported a position in JNJ in Q2 2024 and has held it in 7 quarters since. The position peaked at $389K in Q1 2025. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chris Bulman held 1,353 shares of Johnson & Johnson worth $344K as of Q2 2026.
  • Chris Bulman bought 115 Johnson & Johnson shares in Q2 2026, an estimated $26.8K.
  • Johnson & Johnson made up 0.13% of Chris Bulman's portfolio in Q2 2026, its #110 holding.
  • Chris Bulman first reported a position in Johnson & Johnson in Q2 2024 and has held it in 7 quarters since.
  • Chris Bulman's Johnson & Johnson position peaked at $389K in Q1 2025.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chris Bulman's 13F filing for Q2 2026, filed 22 Jul 2026.